세계의 디지털 PCR 시장 : 산업 분석, 규모, 점유율, 성장 및 동향 예측(2024-2033년)

Persistence Market Research has recently released a comprehensive report on the global Digital PCR Market. The report offers a detailed assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the digital PCR market from 2024 to 2033.

Key Insights:

• Market Size (2024E): USD 183.8 Million
• Projected Market Value (2033F): USD 403.8 Million
• Global Market Growth Rate (CAGR 2024 to 2033): 9.1%

Digital PCR Market - Report Scope:

Digital PCR plays a pivotal role in various applications, including oncology, infectious diseases, and genetic testing. This technology offers superior sensitivity and accuracy in detecting nucleic acids, enabling precise quantification and analysis in research and clinical diagnostics. The digital PCR market serves research laboratories, pharmaceutical companies, diagnostic centers, and academic institutions, offering a range of digital PCR platforms and consumables.

Market Growth Drivers:

The global digital PCR market is driven by several factors, including increasing demand for high precision molecular diagnostics, rising prevalence of chronic diseases, and advancements in digital PCR technology enhancing assay sensitivity and specificity. Growing adoption of personalized medicine approaches and expanding applications in liquid biopsy and rare allele detection further bolster market expansion. Additionally, the shift towards decentralized testing and point-of-care diagnostics accelerates market growth opportunities.

Market Restraints:

Despite promising growth prospects, the digital PCR market faces challenges related to high instrument costs, complex assay development requirements, and regulatory complexities governing diagnostic tests. Variability in assay performance and the need for skilled personnel for data analysis pose additional barriers to market penetration, particularly in resource-limited settings. Addressing these challenges requires continuous innovation in assay design, cost-effective platform development, and strategic collaborations to streamline regulatory pathways.

Market Opportunities:

The digital PCR market presents significant growth opportunities driven by technological innovations, increasing healthcare expenditure, and rising patient demand for personalized diagnostic solutions. Integration of artificial intelligence and machine learning in digital PCR platforms enhances data analysis capabilities and improves diagnostic accuracy. Moreover, expanding applications in non-invasive prenatal testing, infectious disease monitoring, and cancer biomarker analysis broaden market prospects. Strategic partnerships, investment in research and development, and geographic expansion into emerging markets are crucial for capitalizing on evolving opportunities and sustaining competitive advantage.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the global digital PCR market?
• Which applications and end-user segments are propelling adoption of digital PCR technologies?
• How are technological advancements reshaping the competitive landscape of the digital PCR market?
• Who are the key players contributing to the digital PCR market, and what strategies are they employing to maintain market leadership?
• What are the emerging trends and future prospects in the global digital PCR market?

Competitive Intelligence and Business Strategy:

Leading players in the global digital PCR market, including major companies such as Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., and jn medsys, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest significantly in R&D to develop next-generation digital PCR platforms, expand assay portfolios, and enhance automation capabilities. Collaborations with clinical laboratories, biopharmaceutical firms, and regulatory agencies facilitate market access and drive technology adoption. Moreover, emphasis on clinical validation studies, regulatory compliance, and customer education promotes market growth and enhances diagnostic accuracy in the rapidly evolving digital PCR landscape.

Key Companies Profiled:

• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Fluidigm Corp.
• Formulatrix, Inc.
• JN Medsys.
• STILLA TECHNOLOGIES
• Avance Bioscience
• Fluidgm corporation,
• jn medsys
• Merck KGAA
• Precigenome LLC
• QIAGEN N.V
• Sysmex corporation

Key Segments of the Digital PCR Industry

By Product:

• Instrument
• Consumables
• Services

By End User:

• Pharmaceutical Companies
• Research Institutes
• Forensic Labs
• Agriculture Companies

By Application:

• Clinical Diagnostics
• Basic Research
• Applied Research
• Forensic Testing

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Technology Roadmap
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusion and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption Analysis
• 4.2. New Product Launches and Approvals
• 4.3. Regulatory Scenario
• 4.4. Key Promotional Strategies by Manufacturers
• 4.5. Recent Product Launches
• 4.6. PESTEL Analysis
• 4.7. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Industry Outlook
  • 5.1.3. Global PCR Market Analysis
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Top Companies Historical Growth
  • 5.2.2. Technology Advancements in diagnostic imaging
  • 5.2.3. New Product Launches
  • 5.2.4. Growing Geriatric Population
  • 5.2.5. Increasing minimally invasive procedures
  • 5.2.6. Increased Funding and Support from the Government
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

• 6.1. 2024 Market Scenario
• 6.2. COVID-19 and Impact Analysis
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Application
  • 6.2.4. By Region

7. Global Digital PCR Market Demand (in Volume) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market (Volume) Analysis, 2019-2023
• 7.2. Current and Future Market (Volume) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Digital PCR Market - Pricing Analysis

• 8.1. Regional Pricing Analysis, By Product
• 8.2. Global Average Pricing Analysis Benchmark
• 8.3. Pricing Assumptions

9. Global Digital PCR Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2033
  • 10.3.1. Instrument
  • 10.3.2. Consumables
  • 10.3.3. Services
• 10.4. Market Attractiveness Analysis, By Product

11. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By Application

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis by Application, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2033
  • 11.3.1. Clinical Diagnostics
  • 11.3.2. Basic Research
  • 11.3.3. Applied Research
  • 11.3.4. Forensic Testing
• 11.4. Market Attractiveness Analysis, By Application

12. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
  • 12.3.1. Pharmaceutical Companies
  • 12.3.2. Research Institutes
  • 12.3.3. Forensic Labs
  • 12.3.4. Agriculture Companies
• 12.4. Market Attractiveness Analysis, By End User

13. Global Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis by Region, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. South Asia
  • 13.3.5. East Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa
• 13.4. Market Attractiveness Analysis, By Region

14. North America Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Product
  • 14.3.3. By End User
  • 14.3.4. By Application
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By End User
  • 14.4.4. By Application
• 14.5. Key Market Participants - Intensity Mapping
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Market Trends
• 14.8. Country-Level Analysis & Forecast
  • 14.8.1. U.S. Digital PCR Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By End User
      • 14.8.1.2.3. By Application
  • 14.8.2. Canada Digital PCR Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By End User
      • 14.8.2.2.3. By Application

15. Latin America Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Mexico
    • 15.3.1.2. Brazil
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Product
  • 15.3.3. By End User
  • 15.3.4. By Application
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By End User
  • 15.4.4. By Application
• 15.5. Key Market Participants - Intensity Mapping
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Market Trends
• 15.8. Country-Level Analysis & Forecast
  • 15.8.1. Mexico Digital PCR Market
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By End User
      • 15.8.1.2.3. By Application
  • 15.8.2. Brazil Surgical Imaging Market
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By End User
      • 15.8.2.2.3. By Application
  • 15.8.3. Argentina Digital PCR Market
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By End User
      • 15.8.3.2.3. By Application

16. Europe Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. U.K.
    • 16.3.1.2. Germany
    • 16.3.1.3. Italy
    • 16.3.1.4. France
    • 16.3.1.5. Spain
    • 16.3.1.6. Russia
    • 16.3.1.7. BENELUX
    • 16.3.1.8. Rest of Europe
  • 16.3.2. By Product
  • 16.3.3. By End User
  • 16.3.4. By Application
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By End User
  • 16.4.4. By Application
• 16.5. Key Market Participants - Intensity Mapping
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Market Trends
• 16.8. Country-Level Analysis & Forecast
  • 16.8.1. U.K. Digital PCR Market
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By End User
      • 16.8.1.2.3. By Application
  • 16.8.2. Germany Digital PCR Market
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By End User
      • 16.8.2.2.3. By Application
  • 16.8.3. Italy Digital PCR Market
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By End User
      • 16.8.3.2.3. By Application
  • 16.8.4. France Digital PCR Market
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By End User
      • 16.8.4.2.3. By Application
  • 16.8.5. Spain Digital PCR Market
    • 16.8.5.1. Introduction
    • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.5.2.1. By Product
      • 16.8.5.2.2. By End User
      • 16.8.5.2.3. By Application
  • 16.8.6. Russia Digital PCR Market
    • 16.8.6.1. Introduction
    • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.6.2.1. By Product
      • 16.8.6.2.2. By End User
      • 16.8.6.2.3. By Application
  • 16.8.7. BENULUX Digital PCR Market
    • 16.8.7.1. Introduction
    • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.7.2.1. By Product
      • 16.8.7.2.2. By End User
      • 16.8.7.2.3. By Application

17. South Asia Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Indonesia
    • 17.3.1.3. Malaysia
    • 17.3.1.4. Thailand
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. By Product
  • 17.3.3. By End User
  • 17.3.4. By Application
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By End User
  • 17.4.4. By Application
• 17.5. Key Market Participants - Intensity Mapping
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Market Trends
• 17.8. Country-Level Analysis & Forecast
  • 17.8.1. India Digital PCR Market
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By End User
      • 17.8.1.2.3. By Application
  • 17.8.2. Indonesia Digital PCR Market
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By End User
      • 17.8.2.2.3. By Application
  • 17.8.3. Malaysia Digital PCR Market
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By End User
      • 17.8.3.2.3. By Application
  • 17.8.4. Thailand Digital PCR Market
    • 17.8.4.1. Introduction
    • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.4.2.1. By Product
      • 17.8.4.2.2. By End User
      • 17.8.4.2.3. By Application

18. East Asia Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. China
    • 18.3.1.2. Japan
    • 18.3.1.3. South Korea
  • 18.3.2. By Product
  • 18.3.3. By End User
  • 18.3.4. By Application
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By End User
  • 18.4.4. By Application
• 18.5. Key Market Participants - Intensity Mapping
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Key Market Trends
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. China Digital PCR Market
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By End User
      • 18.8.1.2.3. By Application
  • 18.8.2. Japan Digital PCR Market
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By End User
      • 18.8.2.2.3. By Application
  • 18.8.3. South Korea Digital PCR Market
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By End User
      • 18.8.3.2.3. By Application

19. Oceania Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Product
  • 19.3.3. By End User
  • 19.3.4. By Application
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By End User
  • 19.4.4. By Application
• 19.5. Key Market Participants - Intensity Mapping
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Key Market Trends
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. Australia Digital PCR Market
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Product
      • 19.8.1.2.2. By End User
      • 19.8.1.2.3. By Application
  • 19.8.2. New Zealand Digital PCR Market
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Product
      • 19.8.2.2.2. By End User
      • 19.8.2.2.3. By Application

20. Middle East and Africa (MEA) Digital PCR Market Analysis 2019-2023 and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkey
    • 20.3.1.3. South Africa
    • 20.3.1.4. Rest of Middle East and Africa
  • 20.3.2. By Product
  • 20.3.3. By End User
  • 20.3.4. By Application
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product
  • 20.4.3. By End User
  • 20.4.4. By Application
• 20.5. Key Market Participants - Intensity Mapping
• 20.6. Drivers and Restraints - Impact Analysis
• 20.7. Key Market Trends
• 20.8. Country Level Analysis & Forecast
  • 20.8.1. GCC Countries Digital PCR Market
    • 20.8.1.1. Introduction
    • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.1.2.1. By Product
      • 20.8.1.2.2. By End User
      • 20.8.1.2.3. By Application
  • 20.8.2. Turkey Digital PCR Market
    • 20.8.2.1. Introduction
    • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.2.2.1. By Product
      • 20.8.2.2.2. By End User
      • 20.8.2.2.3. By Application
  • 20.8.3. South Africa Digital PCR Market
    • 20.8.3.1. Introduction
    • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.3.2.1. By Product
      • 20.8.3.2.2. By End User
      • 20.8.3.2.3. By Application
  • 20.8.4. North Africa Digital PCR Market
    • 20.8.4.1. Introduction
    • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.4.2.1. By Product
      • 20.8.4.2.2. By End User
      • 20.8.4.2.3. By Application

21. Market Structure Analysis

• 21.1. Market Analysis by Tier of Companies
• 21.2. Market Share Analysis of Top Players
• 21.3. Market Presence Analysis
  • 21.3.1. Regional footprint of Players
  • 21.3.2. Product footprint by Players
  • 21.3.3. Channel footprint by Players

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Benchmarking
• 22.3. Competition Deep Dive
  • 22.3.1. Bio-Rad Laboratories, Inc.
    • 22.3.1.1. Company Overview
    • 22.3.1.2. Product Portfolio
    • 22.3.1.3. Sales Footprint
    • 22.3.1.4. Key Financials
    • 22.3.1.5. SWOT Analysis
    • 22.3.1.6. Key Developments
    • 22.3.1.7. Strategy Overview
      • 22.3.1.7.1. Marketing Strategy
      • 22.3.1.7.2. Product Strategy
      • 22.3.1.7.3. Channel Strategy
  • 22.3.2. Thermo Fisher Scientific Inc.
    • 22.3.2.1. Company Overview
    • 22.3.2.2. Product Portfolio
    • 22.3.2.3. Sales Footprint
    • 22.3.2.4. Key Financials
    • 22.3.2.5. SWOT Analysis
    • 22.3.2.6. Key Developments
    • 22.3.2.7. Strategy Overview
      • 22.3.2.7.1. Marketing Strategy
      • 22.3.2.7.2. Product Strategy
      • 22.3.2.7.3. Channel Strategy
  • 22.3.3. Fluidigm Corp.
    • 22.3.3.1. Company Overview
    • 22.3.3.2. Product Portfolio
    • 22.3.3.3. Sales Footprint
    • 22.3.3.4. Key Financials
    • 22.3.3.5. SWOT Analysis
    • 22.3.3.6. Key Developments
    • 22.3.3.7. Strategy Overview
      • 22.3.3.7.1. Marketing Strategy
      • 22.3.3.7.2. Product Strategy
      • 22.3.3.7.3. Channel Strategy
  • 22.3.4. Formulatrix, Inc.
    • 22.3.4.1. Company Overview
    • 22.3.4.2. Product Portfolio
    • 22.3.4.3. Sales Footprint
    • 22.3.4.4. Key Financials
    • 22.3.4.5. SWOT Analysis
    • 22.3.4.6. Key Developments
    • 22.3.4.7. Strategy Overview
      • 22.3.4.7.1. Marketing Strategy
      • 22.3.4.7.2. Product Strategy
      • 22.3.4.7.3. Channel Strategy
  • 22.3.5. JN Medsys.
    • 22.3.5.1. Company Overview
    • 22.3.5.2. Product Portfolio
    • 22.3.5.3. Sales Footprint
    • 22.3.5.4. Key Financials
    • 22.3.5.5. SWOT Analysis
    • 22.3.5.6. Key Developments
    • 22.3.5.7. Strategy Overview
      • 22.3.5.7.1. Marketing Strategy
      • 22.3.5.7.2. Product Strategy
      • 22.3.5.7.3. Channel Strategy
  • 22.3.6. STILLA TECHNOLOGIES
    • 22.3.6.1. Company Overview
    • 22.3.6.2. Product Portfolio
    • 22.3.6.3. Sales Footprint
    • 22.3.6.4. Key Financials
    • 22.3.6.5. SWOT Analysis
    • 22.3.6.6. Key Developments
    • 22.3.6.7. Strategy Overview
      • 22.3.6.7.1. Marketing Strategy
      • 22.3.6.7.2. Product Strategy
      • 22.3.6.7.3. Channel Strategy
  • 22.3.7. Avance Bioscience
    • 22.3.7.1. Company Overview
    • 22.3.7.2. Product Portfolio
    • 22.3.7.3. Sales Footprint
    • 22.3.7.4. Key Financials
    • 22.3.7.5. SWOT Analysis
    • 22.3.7.6. Key Developments
    • 22.3.7.7. Strategy Overview
      • 22.3.7.7.1. Marketing Strategy
      • 22.3.7.7.2. Product Strategy
      • 22.3.7.7.3. Channel Strategy
  • 22.3.8. Fluidgm corporation,
    • 22.3.8.1. Company Overview
    • 22.3.8.2. Product Portfolio
    • 22.3.8.3. Sales Footprint
    • 22.3.8.4. Key Financials
    • 22.3.8.5. SWOT Analysis
    • 22.3.8.6. Key Developments
    • 22.3.8.7. Strategy Overview
      • 22.3.8.7.1. Marketing Strategy
      • 22.3.8.7.2. Product Strategy
      • 22.3.8.7.3. Channel Strategy
  • 22.3.9. jn medsys
    • 22.3.9.1. Company Overview
    • 22.3.9.2. Product Portfolio
    • 22.3.9.3. Sales Footprint
    • 22.3.9.4. Key Financials
    • 22.3.9.5. SWOT Analysis
    • 22.3.9.6. Key Developments
    • 22.3.9.7. Strategy Overview
      • 22.3.9.7.1. Marketing Strategy
      • 22.3.9.7.2. Product Strategy
      • 22.3.9.7.3. Channel Strategy
  • 22.3.10. Merck KGAA
    • 22.3.10.1. Company Overview
    • 22.3.10.2. Product Portfolio
    • 22.3.10.3. Sales Footprint
    • 22.3.10.4. Key Financials
    • 22.3.10.5. SWOT Analysis
    • 22.3.10.6. Key Developments
    • 22.3.10.7. Strategy Overview
      • 22.3.10.7.1. Marketing Strategy
      • 22.3.10.7.2. Product Strategy
      • 22.3.10.7.3. Channel Strategy
  • 22.3.11. Precigenome LLC
    • 22.3.11.1. Company Overview
    • 22.3.11.2. Product Portfolio
    • 22.3.11.3. Sales Footprint
    • 22.3.11.4. Key Financials
    • 22.3.11.5. SWOT Analysis
    • 22.3.11.6. Key Developments
    • 22.3.11.7. Strategy Overview
      • 22.3.11.7.1. Marketing Strategy
      • 22.3.11.7.2. Product Strategy
      • 22.3.11.7.3. Channel Strategy
  • 22.3.12. QIAGEN N.V
    • 22.3.12.1. Company Overview
    • 22.3.12.2. Product Portfolio
    • 22.3.12.3. Sales Footprint
    • 22.3.12.4. Key Financials
    • 22.3.12.5. SWOT Analysis
    • 22.3.12.6. Key Developments
    • 22.3.12.7. Strategy Overview
      • 22.3.12.7.1. Marketing Strategy
      • 22.3.12.7.2. Product Strategy
      • 22.3.12.7.3. Channel Strategy
  • 22.3.13. Sysmex corporation.
    • 22.3.13.1. Company Overview
    • 22.3.13.2. Product Portfolio
    • 22.3.13.3. Sales Footprint
    • 22.3.13.4. Key Financials
    • 22.3.13.5. SWOT Analysis
    • 22.3.13.6. Key Developments
    • 22.3.13.7. Strategy Overview
      • 22.3.13.7.1. Marketing Strategy
      • 22.3.13.7.2. Product Strategy
      • 22.3.13.7.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology